Home/Filings/4/0001209191-17-043664
4//SEC Filing

Clearside Biomedical, Inc. 4

Accession 0001209191-17-043664

$CLSDQCIK 0001539029operating

Filed

Jul 4, 8:00 PM ET

Accepted

Jul 5, 6:25 PM ET

Size

8.7 KB

Accession

0001209191-17-043664

Insider Transaction Report

Form 4
Period: 2017-06-30
White Daniel H.
DirectorPresident and CEO
Transactions
  • Award

    Common Stock

    2017-06-30$7.74/sh+3,100$23,994503,567 total
Holdings
  • Common Stock

    (indirect: By Trust)
    38,509
  • Common Stock

    (indirect: As UTMA custodian for son)
    844
  • Common Stock

    (indirect: As UTMA custodian for son)
    301
  • Common Stock

    (indirect: As UTMA custodian for son)
    1,188
Footnotes (3)
  • [F1]These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(c) and Rule 16b-3(d).
  • [F2]These securities are held in trust for the benefit of the reporting person's children. The reporting person's wife serves as trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  • [F3]These securities are held for the benefit of the reporting person's son under the Georgia Uniform Transfers to Minors Act, for which the reporting person serves as custodian. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.

Issuer

Clearside Biomedical, Inc.

CIK 0001539029

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001539029

Filing Metadata

Form type
4
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 6:25 PM ET
Size
8.7 KB